Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine for adenoma prevention in rectal stumps and ileal pouches in familial adenomatous polyposis
ACTRN12611001281987Phase 3Not yet recruiting
- Sponsor
- Isadora Rosa
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Salcrozine in Colonic Adenomatous Polyposis and colon adenoma, sponsored by Isadora Rosa. Primary endpoint: Incidence of new adenomas larger than 5 mm in rectal stumps or ileal pouches. Planned start Jun 2012; status: not yet recruiting.
02
Drugs
Salcrozine
03
Conditions
Colonic Adenomatous Polyposiscolon adenoma
Beyond the preview
Go deeper on ACTRN12611001281987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001281987.